Searched for
MSD PHARMACEUTICALS LTD
Aurobindo Pharma enters biologics contract manufacturing with Rs 1,200-crore Telangana facilityAurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. This facility will produce biologic medicines f...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Abbott, MSD Pharmaceuticals ink distribution pact for oral anti-diabetic medicines in IndiaAbbott and MSD Pharmaceuticals have partnered to distribute oral anti-diabetic medicines in India. Abbott will distribute MSD's sitagliptin...
- MSD Pharma, Delhi Capitals partner to create awareness about cervical cancer preventionMSD Pharmaceuticals and Delhi Capitals have partnered to raise cervical cancer prevention awareness in India. The women's T20 team will dis...
- MSD enters pact with UN-backed MPP to license COVID drug molnupiravir in 105 countries including IndiaUnder the terms of the agreement, MPP will be permitted to further license non-exclusive sub-licences to manufacturers and diversify the ma...
- MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of H...
- Hilleman Lab scouts for partners to develop low cost vaccinesHilleman said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some...
- Hilleman Lab to invest Rs 300 crore to develop vaccines"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, c...
- MSD launches medical, healthcare website called 'Univadis'Univadis is an online resource for healthcare professionals launched in 40 countries, available in 17 languages, with 20 mn registered user...
- Patent row: Merck gets interim relief from HCThe Delhi High Court has restrained an Indian pharmaceutical company from launching its diabetes drug manufactured by Merck Sharp and Dohme...
- US drugmaker MSD gets interim relief on diabetes drug patent rowThe US pharma major alleged the Indian company was coming out with the diabetes drug with Sitagliptin molecule and its derivatives salt in ...
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...
- Drug patent row: Merck Sharp and Dohme files appeal against interim order in row with GlenmarkMSD has filed an appeal before the Delhi HC challenging its single bench order refusing to grant interim relief to it on a patent row again...
- MSD India eyes more partnerships to widen product presenceDrug firm MSD India today said it is looking for commercial partnerships, such as the one that it has with Sun Pharma.
- Hilleman Lab to invest about Rs 650 cr to develop vaccinesAs per the company's estimates, it will take 2-4 years in research and development activities to come out with the new vaccine.
- Merck arm to sell cheap diabetes drugThis is perhaps one of the few instances where a drug is cheaper in India, as against its price in other developed markets. (Januvia is pri...
- MSD to launch four vaccines in next two-three yearsMSD Pharmaceuticals, a wholly- owned subsidiary of Merck & Co, plans to launch vaccines for Chicken pox, Hepitatis A, Rotavirus and Zoster ...
- MSD Pharma launches JANUVIA for diabetic careDrug firm MSD Pharmaceuticals today launched its patent medicine under the brand name 'JANUVIA' in diabetic care segment and aims to tap fo...
Load More
